Abstract

Abstract Introduction: Phytochemicals and dietary antioxidants are known to decrease the risk of inflammation and prevent cancer development. We have developed strategies to inhibit cancer progression and its spread by natural products. A nutrient mixture (NM) containing ascorbic acid, lysine, proline and green tea extract has exhibited anticancer activity in vitro and in vivo in a number of cancer cell lines. Objective: We investigated the effect of NM on human lymphoma cell line U-937 in vitro by measuring: cell proliferation, MMP expression, invasion, apoptosis, and Cox-2 and Cox-1 protein expression. Materials and Methods: Human lymphoma cell line U-937 (ATCC) was cultured in RPMI medium supplemented with fetal bovine serum and antibiotics. U-937 cells were seeded on 24-well tissue culture plates with 40nM phorbol 12-myristate 13-acetate (PMA). After 24 hrs, the cells were treated with NM at 0, 50, 100, 250, 500 and 1000 mcg/ml, in triplicate at each dose. Cell proliferation was evaluated by MTT assay, MMP expression by gelatinase zymography, invasion through Matrigel, apoptosis by using live green caspase detection kit (Molecular Probe), and COX-2 and COX-1 expression by Western blot. Results: NM was not toxic to U-937 cells at a concentration of 250 mcg/ml and exhibited an antiproliferative effect at 500 mcg/ml concentration. Zymography demonstrated only one band corresponding to MMP-9, which was inhibited by NM in a dose-dependent manner. Matrigel invasion was significantly reduced (by 95%) at 250 mcg/ml NM and completely blocked at 500 mcg/ml NM. NM induced slight apoptosis at 100 mcg/ml and moderate at 500 and 1000 mcg/ml concentration. NM inhibited Cox-2 expression in a dose-dependent fashion and had no effect on Cox-1 expression. Conclusions: Our results suggest that NM is an excellent candidate for therapeutic use in the treatment of hematological malignancies. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2261.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.